Redafamdastat

N/A

Report date: 2025/03/14 13:45:06
NME

Base Information

Drug NameRedafamdastat
Drug Alias NamePF-7845PF-4457845PF-04457845JZP-150
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFatty-acid amide hydrolase 2 inhibitors
TargetsFatty-acid amide hydrolase 2
Therapy Area/IndicationsStress Disorders, Post-TraumaticSleepFear +[8] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesSingapore +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesYale UniversityJazz Pharmaceuticals IncJazz Pharmaceuticals Plc
Inactive CompaniesPfizer Inc
Active IndicationsStress Disorders, Post-TraumaticMarijuana Abuse
Inactive IndicationsSleepFearChronic Pain +[6] 

Other Information

ATC CodeN/A
Related LinksWikipedia